Abstract
Background and study aim:
Renal complications are frequent extraintestinal manifestations in inflammatory bowel disease (IBD). We aimed in our study to describe the spectrum of renal affection in our IBD patients.
Patients and methods:
This study is a retrospective analysis of renal biopsies done for IBD patients who developed renal diseases, at Cairo University Hospital, from June 2005 to Jan. 2016. Results : Among 896 IBD patients, 218 patients (24.3%) developed renal affection. The onset of renal disease mandated renal biopsy at 5.6 ± 7.4 years after IBD diagnosis. Nephrotic range proteinuria was the most common indication for a renal biopsy [81 (37.15%) patients]. Amyloidosis was the most common renal pathological diagnosis [56 patients (25.7%)] followed by immunoglobulin A (IgA) nephropathy [35 patients (16.1%)], focal segmental glome- rulosclerosis (FSGS) [32patients (14.7%)], crescentic glomerulonephritis (CGN) [32 patients (14.7%)], membranous nephropathy (MN) [18 patients (8.25%)], minimal change disease [17 patients (7.7%)], chronic interstitial nephritis (CIN) [10 patients (4.6%)], acute tubular necrosis (ATN) [8 patients (3.7%)], thrombotic microangiopathy (TMA) [6 patients (2.75%)], and acute interstitial nephritis (AIN)[4 patients (1.8%)]. Variable renal histopathology diagnoses did not correlate with age, duration of IBD diagnosis, or drugs used for IBD treatment. Crescentic GN was significantly correlating with ASCA, ANCA-p, and ANCA-c in serum.
Conclusion:
Amyloidosis is a common renal pathological diagnosis in our patients, and is followed by IgA nephropathy, and FSGS.
Keywords:
IBD; IgA nephropathy; amyloidosis; renal complications.
© Acta Gastro-Enterologica Belgica.
MeSH terms
-
Acute Disease
-
Adult
-
Amyloidosis / epidemiology
-
Amyloidosis / etiology
-
Amyloidosis / metabolism
-
Amyloidosis / pathology
-
Antibodies, Antineutrophil Cytoplasmic / metabolism
-
Biopsy
-
Egypt / epidemiology
-
Female
-
Glomerulonephritis / epidemiology
-
Glomerulonephritis / etiology
-
Glomerulonephritis / metabolism
-
Glomerulonephritis / pathology
-
Glomerulonephritis, IGA / epidemiology
-
Glomerulonephritis, IGA / etiology
-
Glomerulonephritis, IGA / metabolism
-
Glomerulonephritis, IGA / pathology
-
Glomerulonephritis, Membranous / epidemiology
-
Glomerulonephritis, Membranous / etiology
-
Glomerulonephritis, Membranous / metabolism
-
Glomerulonephritis, Membranous / pathology
-
Glomerulosclerosis, Focal Segmental / epidemiology
-
Glomerulosclerosis, Focal Segmental / etiology
-
Glomerulosclerosis, Focal Segmental / metabolism
-
Glomerulosclerosis, Focal Segmental / pathology
-
Humans
-
Inflammatory Bowel Diseases / complications
-
Inflammatory Bowel Diseases / epidemiology
-
Inflammatory Bowel Diseases / physiopathology*
-
Kidney Cortex Necrosis / epidemiology
-
Kidney Cortex Necrosis / etiology
-
Kidney Cortex Necrosis / metabolism
-
Kidney Cortex Necrosis / pathology
-
Kidney Diseases / epidemiology
-
Kidney Diseases / etiology
-
Kidney Diseases / metabolism
-
Kidney Diseases / pathology*
-
Male
-
Middle Aged
-
Nephritis, Interstitial / epidemiology
-
Nephritis, Interstitial / etiology
-
Nephritis, Interstitial / metabolism
-
Nephritis, Interstitial / pathology
-
Nephrosis, Lipoid / epidemiology
-
Nephrosis, Lipoid / etiology
-
Nephrosis, Lipoid / metabolism
-
Nephrosis, Lipoid / pathology
-
Nephrotic Syndrome / epidemiology
-
Nephrotic Syndrome / etiology
-
Nephrotic Syndrome / metabolism
-
Nephrotic Syndrome / pathology
-
Proteinuria / epidemiology
-
Proteinuria / etiology
-
Proteinuria / metabolism
-
Proteinuria / pathology
-
Renal Insufficiency, Chronic / epidemiology
-
Renal Insufficiency, Chronic / etiology
-
Renal Insufficiency, Chronic / metabolism
-
Renal Insufficiency, Chronic / pathology
-
Retrospective Studies
-
Thrombotic Microangiopathies / epidemiology
-
Thrombotic Microangiopathies / etiology
-
Thrombotic Microangiopathies / metabolism
-
Thrombotic Microangiopathies / pathology
Substances
-
Antibodies, Antineutrophil Cytoplasmic